The IP-ABM has also been studied extensively to enhance radiopharmaceuticals (small molecules and peptides), where the group at the para-position of the aromatic ring of the IP-ABM can be tuned to adjust serum albumin affinity [15,27,28], and a neighboring aspartate residue (D) has been shown to provide a more sustained tumor retention [29]. Here, ALB is linked to neoplasm.